NCNO files Form 144 to sell 334,969 shares via Merrill Lynch on 09/08/2025
Rhea-AI Filing Summary
Form 144 notice for nCino, Inc. (NCNO): The filer reported a proposed sale of 334,969 shares of common stock through Merrill Lynch Pierce Fenner and Smith (One Bryant Park, New York). The aggregate market value of the proposed sale is $10,183,057.60, with approximately 115,814,720 shares outstanding. The approximate date of sale is 09/08/2025. The securities were acquired on 06/15/2020 in a private placement from the issuer, with payment made in cash. The filer reports no securities sold during the past 3 months and includes the standard representation that they are not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Form 144 filing disclosing a proposed sale of 334,969 shares via a broker; no recent sales reported.
The filing documents a proposed public resale under Rule 144 of 334,969 shares of common stock valued at $10,183,057.60, to be executed through Merrill Lynch on 09/08/2025. The shares were acquired in a private placement on 06/15/2020 and were paid for in cash. The notice confirms no sales in the prior three months and includes the customary assurance that no undisclosed material adverse information exists. This is a disclosure of intent rather than evidence of completed market activity; it provides transparency around potential share supply but does not, by itself, indicate material change to company fundamentals.
TL;DR: Procedural disclosure consistent with Rule 144; identifies acquisition origin and broker but omits named seller details in this extract.
The form shows the securities originated from a private placement with the issuer and will be sold through a major brokerage firm. The filing includes the signature representation about undisclosed material adverse information. The document as provided does not list the specific person for whose account the sale is proposed in the visible fields, which limits assessment of potential insider status or related governance implications. As presented, this is a standard compliance filing under securities resale rules.